Subscribe8,000+ International Professionals From Industry, Academia, And Regulatory Agencies Convene In Philadelphia.
1,000+ Speakers, 350+ Sessions And Keynoter Dr. Sanjay Gupta
PHILADELPHIA - Feb. 17, 2006 - From the initial stages of R&D to clinical trials through regulatory approval and product marketing, the pharmaceutical and biotechnology industries must continually respond to critical advancements and changing regulatory requirements.
Join more than 8,000 industry, academia, and regulatory professionals from across the world at the Drug Information Association's (DIA) 42nd Annual Meeting - the largest neutral forum in the life sciences field dedicated to biopharm life cycle challenges - on June 18-22, 2006 at the Pennsylvania Convention Center.
Hosted in Philadelphia - the heart of the pharmaceutical industry corridor, where DIA was founded and remains headquartered - the conference offers attendees more than 350 sessions with 1,000+ speakers, including representatives from the FDA, EMEA and other regulatory agencies.
Industry professionals can register for one of 43 pre-conference tutorials, select from sessions in 29 tracks and network with more than 430 exhibiting companies including clinical research organizations (CRO), technology providers and academic research site centers.
Highlights of the four-day annual event include: a special plenary session with the FDA, Office of the Commissioner on Tuesday, June 20 at 3:30 p.m., followed by a reception recognizing the 100th year of the FDA; joint FDA and EMEA panel discussions addressing current and upcoming regulatory guidelines; and the FDA Center for Drug Evaluation and Review (CDER) Annual Town Hall, an interactive session where attendees can submit questions to senior CDER leaders.
"Since our founding more than four decades ago, DIA has been committed to providing a neutral educational forum to our more than 23,000 members," said Theresa K. Musser, president of the DIA board of directors. "The annual meeting is the one event where professionals who bring new medicines and vaccines to populations worldwide can gather to learn about best practices and the latest in regulations governing those practices."
Neurosurgeon Sanjay Gupta, MD, senior medical correspondent for CNN's health and medical unit, will deliver the keynote address on Monday, June 19. Nationally known for medical journalism, Gupta's hosts CNN's "House Call with Dr. Sanjay Gupta", co-hosts TNT's "Accent Health" and writes a health column for TIME magazine.
He recently received the National Headliner Award for "The First Patient: Health and the Presidency," a prime-time health-related television special. In addition, Gupta serves as staff and faculty member of the department of neurosurgery at Emory University School of Medicine in Atlanta and is chief of neurosurgery at Grady Memorial Hospital.
"We look forward to welcoming Dr. Gupta and a record number of more than 8,000 professionals to our 42nd annual meeting in Philadelphia," said Charles Depew, PharmD, 2006 Annual Meeting Program Chairperson. "From the much anticipated FDA plenary session to the hundreds of sessions offered in 29 different content tracks, the event will provide diverse presentations and case studies to professionals who have a common goal - to deliver and develop new, safe and effective medicines."
Early bird conference registration is available to DIA members through February 10, 2006. Special government, non-profit and academia rates are also available. Register online at www.diahome.org and view a full program at http://www.diahome.org/product/9137/06001.pdf.
For more information, contact Lori Risboskin, director of DIA's Annual Meeting, at 215-442-6174 or lori.Risboskin@diahome.org. Media interested in attending the event or arranging for pre- or post-event interviews should contact DIA's public relations firm, Toplin & Associates, Inc., by calling Heather Cable at 215-793-4666 or by e-mailing heather@toplin.com.